Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease

Human Molecular Genetics

Volumn 19, Issue 17, 2010, Pages 3372-3382

  Besson, Marie Thérèse ^a   Dupont, Pascale ^a   Fridell, Yih Woei C ^b   Liévens, Jean Charles ^a  

^a University of Mediterranée   (France)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATALASE; GLUCOSE TRANSPORTER 1; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DEATH; DNA MODIFICATION; DROSOPHILA; ENERGY METABOLISM; GENE EXPRESSION; GLIA; GLUCOSE TRANSPORT; HUNTINGTON CHOREA; LIFE EXPECTANCY; LOCOMOTION; MITOCHONDRIAL RESPIRATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DROSOPHILA; DROSOPHILA PROTEINS; ENERGY METABOLISM; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MITOCHONDRIAL PROTEINS; NEUROGLIA; NEURONS; OXIDATIVE STRESS;

EID: 77955376527     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq249     Document Type: Article

References (57)

1. Hebb, M.O., Denovan-Wright, E.M. and Robertson, H.A. (1999) Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB J., 13, 1099-1106.
2. Shin, J.Y., Fang, Z.H., Yu, Z.X., Wang, C.E., Li, S.H. and Li, X.J. (2005) Expression of mutant Huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol., 171, 1001-1012.
3. Liévens, J.C., Iché, M., Laval, M., Faivre-Sarrailh, C. and Birman, S. (2008) AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease. Hum. Mol. Genet., 17, 882-894.
4. Tamura, T., Sone, M., Yamashita, M., Wanker, E.E. and Okazawa, H. (2009) Glial cell lineage expression of mutant ataxin-1 and Huntingtin induces developmental and late-onset neuronal pathologies in Drosophila models. PLoS ONE, 4, e4262.
5. Bradford, J., Shin, J.Y., Roberts, M., Wang, C.E., Li, X.J. and Li, S. (2009) Expression of mutant Huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc. Natl Acad. Sci. USA, 106, 22480-22485.
6. Liévens, J.C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L. and Bates, G.P. (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Dis., 8, 807-821.
7. Behrens, P.F., Franz, P., Woodman, B., Lindenberg, K.S. and Landwehrmeyer, G.B. (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain, 125, 1908-1922.
8. Arzberger, T., Krampfl, K., Leimgruber, S. and Weindl, A. (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study. J. Neuropathol. Exp. Neurol., 56, 440-454.
9. Hassel, B., Tessler, S., Faull, R.L. and Emson, P.C. (2007) Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem. Res., 33, 232-237.
10. Liévens, J.C., Rival, T., Iche, M., Chneiweiss, H. and Birman, S. (2005) Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum. Mol. Genet., 14, 713-724.
11. Hyder, F., Patel, A.B., Gjedde, A., Rothman, D.L., Behar, K.L. and Shulman, R.G. (2006) Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J. Cereb. Blood Flow Metab., 26, 865-877.
12. Jolivet, R., Magistretti, P.J. and Weber, B. (2009) Deciphering neuronglia compartmentalization in cortical energy metabolism. Front. Neuroenergetics, 1,4.
13. Damiano, M., Galvan, L., Déglon, N. and Brouillet, E. (2010) Mitochondria in Huntington's disease. Biochim. Biophys. Acta, 1802, 52-61.
14. Browne, S.E. (2008) Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Ann. N. Y. Acad. Sci., 1147, 358-382.
15. Browne, S.E., Bowling, A.C., MacGarvey, U., Baik, M.J., Berger, S.C., Muqit, M.M., Bird, E.D. and Beal, M.F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol., 41, 646-653.
16. Gu, M., Gash, M.T., Mann, V.M., Javoy-Agid, F., Cooper, J.M. and Schapira, A.H. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol., 39, 385-389.
17. Tabrizi, S.J., Cleeter, M.W., Xuereb, J., Taanman, J.W., Cooper, J.M. and Schapira, A.H. (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol., 45, 25-32.
18. Sorolla, M.A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J. and Cabiscol, E. (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic. Biol. Med., 45, 667-678.
19. Tabrizi, S.J., Workman, J., Hart, P.E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J.M. and Schapira, A.H. (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol., 47, 80-86.
20. Zourlidou, A., Gidalevitz, T., Kristiansen, M., Landles, C., Woodman, B., Wells, D.J., Latchman, D.S., de Belleroche, J., Tabrizi, S.J., Morimoto, R.I. et al. (2007) Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum. Mol. Genet., 16, 1078-1090.
21. Butterworth, J., Yates, C.M. and Reynolds, G.P. (1985) Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases. J. Neurol. Sci., 67, 161-171.
22. Sorbi, S., Bird, E.D. and Blass, J.P. (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol., 13, 72-78.
23. Browne, S.E. and Beal, M.F. (2006) Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox Signal., 8, 2061-2073.
24. Brand, A.H. and Perrimon, N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development, 118, 401-415.
25. Bouillaud, F. (2009) UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. Biochim. Biophys. Acta, 1787, 377-383.
26. Andrews, Z.B., Diano, S. and Horvath, T.L. (2005) Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nat. Rev. Neurosci., 6, 829-840.
27. Kim-Han, J.S. and Dugan, L.L. (2005) Mitochondrial uncoupling proteins in the central nervous system. Antioxid. Redox Signal., 7, 1173-1181.
28. Jezek, P. (2002) Possible physiological roles of mitochondrial uncoupling proteins-UCPn. Int. J. Biochem. Cell Biol., 34, 1190-1206.
29. Fridell, Y.W., Sanchez-Blanco, A., Silvia, B.A. and Helfand, S.L. (2004) Functional characterization of a Drosophila mitochondrial uncoupling protein. J. Bioenerg. Biomembr., 36, 219-228.
30. Rival, T., Soustelle, L., Strambi, C., Besson, M.T., Iche, M. and Birman, S. (2004) Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr. Biol., 14, 599-605.
31. Sanchez-Blanco, A., Fridell, Y.W. and Helfand, S.L. (2006) Involvement of Drosophila uncoupling protein 5 in metabolism and aging. Genetics, 172, 1699-1710.
32. Agrawal, N., Pallos, J., Slepko, N., Apostol, B.L., Bodai, L., Chang, L.W., Chiang, A.S., Thompson, L.M. and Marsh, J.L. (2005) Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc. Natl Acad. Sci. USA, 102, 3777-3781.
33. Fahrbach, S.E. (2006) Structure of the mushroom bodies of the insect brain. Annu. Rev. Entomol., 51, 209-232.
34. Fridell, Y.W., Sanchez-Blanco, A., Silvia, B.A. and Helfand, S.L. (2005) Targeted expression of the human uncoupling protein 2 (hUCP2) to adult neurons extends life span in the fly. Cell. Metab., 1, 145-152.
35. Negre-Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R., Penicaud, L. and Casteilla, L. (1997) A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. Faseb J., 11, 809-815.
36. Mattiasson, G., Shamloo, M., Gido, G., Mathi, K., Tomasevic, G., Yi, S., Warden, C.H., Castilho, R.F., Melcher, T., Gonzalez-Zulueta, M. et al. (2003) Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med., 9, 1062-1068.
37. Bayne, A.C., Mockett, R.J., Orr, W.C. and Sohal, R.S. (2005) Enhanced catabolism of mitochondrial superoxide/hydrogen peroxide and aging in transgenic Drosophila. Biochem. J., 391, 277-284.
38. Escher, S.A. and Rasmuson-Lestander, A. (1999) The Drosophila glucose transporter gene: cDNA sequence, phylogenetic comparisons, analysis of functional sites and secondary structures. Hereditas, 130, 95-103.
39. Trotta, N., Rodesch, C.K., Fergestad, T. and Broadie, K. (2004) Cellular bases of activity-dependent paralysis in Drosophila stress-sensitive mutants. J. Neurobiol., 60, 328-347.
40. Fergestad, T., Bostwick, B. and Ganetzky, B. (2006) Metabolic disruption in Drosophila bang-sensitive seizure mutants. Genetics, 173, 1357-1364.
41. Fuller, P.M., Warden, C.H., Barry, S.J. and Fuller, C.A. (2000) Effects of 2-G exposure on temperature regulation, circadian rhythms, and adiposity in UCP2/3 transgenic mice. J. Appl. Physiol., 89, 1491-1498.
42. Horvath, T.L., Diano, S., Miyamoto, S., Barry, S., Gatti, S., Alberati, D., Livak, F., Lombardi, A., Moreno, M., Goglia, F. et al. (2003) Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int. J. Obes. Relat. Metab. Disord., 27, 433-442.
43. Diano, S., Matthews, R.T., Patrylo, P., Yang, L., Beal, M.F., Barnstable, C.J. and Horvath, T.L. (2003) Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology, 144, 5014-5021.
44. Deierborg, T., Wieloch, T., Diano, S., Warden, C.H., Horvath, T.L. and Mattiasson, G. (2008) Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J. Cereb. Blood Flow Metab., 28, 1186-1195.
45. Andrews, Z.B., Horvath, B., Barnstable, C.J., Elsworth, J., Yang, L., Beal, M.F., Roth, R.H., Matthews, R.T. and Horvath, T.L. (2005) Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J. Neurosci., 25, 184-191.
46. Conti, B., Sugama, S., Lucero, J., Winsky-Sommerer, R., Wirz, S.A., Maher, P., Andrews, Z., Barr, A.M., Morale, M.C., Paneda, C. et al. (2005) Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J. Neurochem., 93, 493-501.
47. Pecqueur, C., Bui, T., Gelly, C., Hauchard, J., Barbot, C., Bouillaud, F., Ricquier, D., Miroux, B. and Thompson, C.B. (2008) Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. Faseb J., 22, 9-18.
48. Skulachev, V.P. (1991) Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. FEBS Lett., 294, 158-162.
49. Garlid, K.D., Orosz, D.E., Modriansky, M., Vassanelli, S. and Jezek, P. (1996) On the mechanism of fatty acid-induced proton transport by mitochondrial uncoupling protein. J. Biol. Chem., 271, 2615-2620.
50. Warburg, O. (1956) On the origin of cancer cells. Science, 123, 309-314.
51. Liu, D., Chan, S.L., de Souza-Pinto, N.C., Slevin, J.R., Wersto, R.P., Zhan, M., Mustafa, K., de Cabo, R. and Mattson, M.P. (2006) Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Med., 8, 389-414.
52. Huppertz, C., Fischer, B.M., Kim, Y.B., Kotani, K., Vidal-Puig, A., Slieker, L.J., Sloop, K.W., Lowell, B.B. and Kahn, B.B. (2001) Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism. J. Biol. Chem., 276, 12520-12529.
53. Garcia-Martinez, C., Sibille, B., Solanes, G., Darimont, C., Mace, K., Villarroya, F. and Gomez-Foix, A.M. (2001) Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation. Faseb J., 15, 2033-2035.
54. Pellerin, L. and Magistretti, P.J. (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl Acad. Sci. USA, 91, 10625-10629.
55. Ravikumar, B., Stewart, A., Kita, H., Kato, K., Duden, R. and Rubinsztein, D.C. (2003) Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant Huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. Hum. Mol. Genet., 12, 985-994.
56. Kita, H., Carmichael, J., Swartz, J., Muro, S., Wyttenbach, A., Matsubara, K., Rubinsztein, D.C. and Kato, K. (2002) Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum. Mol. Genet., 11, 2279-2287.
57. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.